logo
Plus   Neg
Share
Email

Clariant Names Stephan Lynen CFO, Succeeding Patrick Jany, Effective April 1

Swiss specialty chemicals company Clariant AG (CLZNY.PK,CRN.L,CLZNF.PK) announced Wednesday the appointment of Stephan Lynen as Chief Financial Officer as of April 1.

Lynen, currently Head of the Business Unit Additives, succeeds Patrick Jany, who is leaving the company to be the CFO of A.P. Moller - Maersk, a shipping services company.

The newly appointed CFO has been with the company for more than 20 years in various international general management and business roles. He joined Clariant in 1998 as a Corporate Internal Auditor.

Clariant said its Board of Directors at Tuesday's meeting accepted Jany's resignation and approved Lynen's appointment as new CFO.

Jany had been with the company for 25 years, and was CFO since 2006.

At A.P. Moller - Maersk, Jany will be succeeding Carolina Dybeck, who in November last year was appointed by General Electric Co. (GE) as Senior Vice President and Chief Financial Officer.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Samsung Electronics Co Ltd (SMSN.L, SSNNF.OB, SSNLF.OB) expects that its first-quarter operating profit will increase about 2.73 percent from last year, sales will also increase 4.98 percent. JPMorgan Chase CEO Jamie Dimon said it expects the bank's earnings to be "down meaningfully" in 2020 due to the disruptions created by coronavirus pandemic. He also noted that the U.S. was not adequately prepared for the pandemic. In his annual letter to the company's shareholders, Dimon said that the bank's board may consider suspending the dividend in an extremely adverse scenario. The U.S. Food and Drug Administration launched a national effort to facilitate the development of blood-related therapies to combat the ongoing coronavirus (COVID-19) pandemic. The FDA is focused on two investigational therapies derived from human blood called convalescent plasma and hyperimmune globulin, which are antibody-rich blood products made from blood donated by people who have recovered.
Follow RTT
>